Company Celyad Oncology SA OTC Markets
Equities
CYADY
US1512052002
Biotechnology & Medical Research
Business Summary
Number of employees: 18
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cardiology
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe and United States
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michel Lussier
FOU | Founder | 67 | 24/07/24 |
David Georges
DFI | Director of Finance/CFO | - | 01/19/01 |
Eytan Breman
CTO | Chief Tech/Sci/R&D Officer | - | 01/15/01 |
An Phan
LAW | General Counsel | 49 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michel Lussier
FOU | Founder | 67 | 24/07/24 |
Hilde Windels
CHM | Chairman | 59 | 07/18/07 |
Serge Goblet
BRD | Director/Board Member | - | 01/08/01 |
Director/Board Member | 53 | 20/22/20 | |
Director/Board Member | - | - | |
Director/Board Member | 50 | 06/20/06 | |
Sage Mandel
BRD | Director/Board Member | - | - |
Marina Udier
BRD | Director/Board Member | - | 11/11/11 |
Ami Patel Shah
BRD | Director/Board Member | - | 08/21/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,428,572 | 38,267,083 ( 92.37 %) | 0 | 92.37 % |
Company contact information
Celyad Oncology SA
Axis Business Park Rue André Dumont 9
1435, Mont-Saint-Guibert
+32 1 039 41 00
http://www.celyad.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+43.36% | 5.81TCr | |
-5.31% | 4.05TCr | |
+37.52% | 3.9TCr | |
+14.75% | 2.67TCr | |
-12.56% | 2.66TCr | |
-22.45% | 1.9TCr | |
+0.04% | 1.22TCr | |
+25.12% | 1.2TCr | |
+26.04% | 1.19TCr |